Chimerix Inc (CMRX) is trading 10% higher at $2.37 today. The Health Care sector is having a generally meh day, this hasn't really affected the stock's share price, as it quickly outshining other names in the space.


Chimerix Inc has been trading between a 52-week high of $7.42 and a 52-week low of $1.27. The stock has a market cap of $208 Million.

Chimerix is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. The company's three most advanced clinical-stage development programs are BCV, ONC201 and DSTAT. BCV is an antiviral drug candidate developed as a potential medical countermeasure for smallpox and is currently under review for regulatory approval in the United States.

Chimerix Inc. (NASDAQ: CMRX) Forecast: Expect A -370.09% Drop Within A Few Months
Stocks Register 08-26-22

Chimerix: A Confusing Business Strategy Makes It Unconvincing (NASDAQ:CMRX)
Seeking Alpha 08-23-22

Chimerix: Advancement For Rare Brain Cancer Drug Targeting Specific Mutation
Seeking Alpha 08-23-22

Chimerix Inc.’s (NASDAQ: CMRX) Stock Forecast: Increase To $11.00 In A Year
Stocks Register 08-23-22

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
InvestorPlace 08-17-22